The Philippine Competition Commission (PCC) has approved the purchase by conglomerate Udenna Corporation of a Dutch company that will give its owner, Dennis Uy, a majority stake in shipping company 2GO Incorporated after it complied with the Commission’s demands.
The PCC previously nullified Udenna’s purchase of the entire outstanding capital stock of KGLI-BV and imposed a 19.6-million pisos (US$377,255) fine as the deal was finalized without clearance from the Commission.
Udenna and KGLI-BV filed their notification on March 23 and entered PCC review on April 5. The firms also paid the fine on April 19 at the National Treasury as part of the compliance order, said the PCC.
“While we reiterated that we acted in good faith in consummating the transaction based on our interpretation of the then newly issued rules, we respected the decision and submitted to the process of having the transaction approved,” Adel Tamano, vice president for corporate affairs at Udenna, said in a statement.
After the firms’ compliance, the PCC wrote in its decision that Udenna’s acquisition of the outstanding stock of KGLI-BV “is not likely to result in lessening of competition within the Philippine market,” as there are no existing overlaps between the parties.
Full Content: CBN
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas